InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: Bill_ENG post# 151033

Sunday, 03/07/2021 12:38:36 PM

Sunday, March 07, 2021 12:38:36 PM

Post# of 233203
Agreed. We will get there in 3 months! I know this was said before and majority of the shareholders have been patient but this is what investing in small biotech is all about. Lots of DD and trusting the science to deliver. FDA could have easily slammed the door on us if they didn’t believe, but instead they are giving us another opportunity to knock it out of the park! CYDY is not going anywhere. I am confident we will be in double digit in 6 months even if there is some dilution along the way. Who knows we could gap up tomorrow! :)

By the way, the therapeutic market for critical COVID patients is unfortunately not going away for another 5 yrs at the very least. And we will certainly be the major beneficiaries.

Remember this is what Dr. Seethamraju said and he will be part of the conference call tomorrow afternoon!

Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, commented, “The CD12 trial results are very promising and leronlimab may be the only safe medication to help critically ill patients.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News